Australia's Neuren Pharma surges over 10% on US patent win for rare disease drug – RP Digital

Business

Australia's Neuren Pharma surges over 10% on US patent win for rare disease drug

June 26, 20251 min0

Australia's Neuren Pharma surges over 10% on US patent win for rare disease drug

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250